孟鲁司特联合酮替芬治疗感冒后咳嗽疗效观察

王剑利,俞珊,李净

武警医学 ›› 2013, Vol. 24 ›› Issue (7) : 600-601.

PDF(423 KB)
PDF(423 KB)
武警医学 ›› 2013, Vol. 24 ›› Issue (7) : 600-601.
论著

孟鲁司特联合酮替芬治疗感冒后咳嗽疗效观察

  • 王剑利1,俞珊2,李净2
作者信息 +

Clinical observation of montelukast combined with ketotifen in treating cough after common cold

  • WANG Jianli1,YU Shan2,and LI Jing2.
Author information +
文章历史 +

摘要

目的观孟鲁司特联合酮替芬治疗感冒后咳嗽的临床疗效。方法感冒后咳嗽患者216例,随机分为治疗组108例和对照组108例,治疗组口服孟鲁司特+酮替芬+复方甘草口服溶液;对照组口服氯雷他定+复方甘草口服溶液。比较两组临床有效率、咳嗽缓解时间及不良反应。结果治疗组临床有效率90.7%;对照组临床有效率为66.7%。治疗组咳嗽缓解时间为(3±1.57)d,对照组为(5±2.36)d。两组不良反应症状均较轻微。结论孟鲁司特联合酮替芬治疗感冒后咳嗽安全有效,并明显缩短治疗周期。

Abstract

Objective To evaluate the clinical effect of montelukast combined with ketotifen in treating cough after common cold. Methods A total of 216 patients were randomly divided into two groups: 108 patients in study group were treated with montelukast combined with ketotifen and compound glycyrrhiza oral solution; 108 patients in control group were treated with and compound glycyrrhiza oral solution alone. The effective rates, cough time, and side effects were compared. Results The effective rate in study group was 90.7%, and 66.7% in control group. The cough remission time was (3?1.57) days in study group, and (5?2.36) days in control group. The side effects were trivial in two groups. Conclusion Montelukast combined with ketotifen is effective and safe to treat cough after common, and can be used widely.

关键词

孟鲁司特 / 酮替芬 / 感冒咳嗽

Key words

montelukast / ketotifen / cough after common cold

引用本文

导出引用
王剑利,俞珊,李净. 孟鲁司特联合酮替芬治疗感冒后咳嗽疗效观察[J]. 武警医学. 2013, 24(7): 600-601
WANG Jianli,YU Shan,and LI Jing.. Clinical observation of montelukast combined with ketotifen in treating cough after common cold[J]. Medical Journal of the Chinese People Armed Police Forces. 2013, 24(7): 600-601
中图分类号: R373.14   

参考文献

[1] 顾燕玉.孟鲁斯特治疗感冒后咳嗽的临床观察[J].北方药学,2012,9(3):78-83.

[2] 中华医学会呼吸病学分会哮喘学组.咳嗽的诊断与治疗指南(2009版)[J].全科医学临床与教育,2009,1(5):454.

[3] Irwin R S, Baumann M H, Bolser D C, et al. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines[J]. Chest,2006,129(Suppl 1):1S-23S.

[4] Morice A H, Fontana G A, Sovijarvi A R, et al. The diagnosis and management of chronic cough[J]. Eur Respir J, 2004,24:481-492.

[5] Peter V D.Cough: an unmet clinical need[J]. Br J Pharmacol, 2011, 163(1): 116-124.

[6] 陆月明.慢性咳嗽诊断与治疗[M].上海:第二军医大学出版社,2007:56-59.

[7] 陈如冲,刘春丽,罗 炜,等.感冒后咳嗽敏感性及气道神经源性炎症改变[J].中国实用内科杂志,2007,27(9):674-677.

[8] 王 迪,于丽娜.孟鲁司特治疗成人感染后咳嗽的临床观察[J].中国医药指南,2012,10(7):11-12.

[9] Braman S S. Postinfectious cough: ACCP evidence-based clinical practice guidelines[J]. Chest,2006,129(Suppl 1):138S-146S.

[10] Kita T, Fujimura M, Ogawa H,et al. Antitussive effects of the leukotriene receptor antagonist montelukast in patients with cough variant asthma and atopic cough[J]. Allergol Int,2010,59:185-192.

[11] 潘殿柱,柴文戍,刘 砚,等. 单独和联合应用孟鲁司特、沙美特罗替卡松治疗成人感染后咳嗽的疗效比较[J]. 中国药房,2012 ,23 (6 ): 553-555.

[12] 黄建会,黄健兰.氨茶碱加酮替芬治疗感冒后咳嗽118例疗效分析[J].现代医药卫生,2011,27(17):2592-2593.

PDF(423 KB)

Accesses

Citation

Detail

段落导航
相关文章

/